Your browser doesn't support javascript.
loading
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma.
Figlin, Robert A; Tannir, Nizar M; Uzzo, Robert G; Tykodi, Scott S; Chen, David Y T; Master, Viraj; Kapoor, Anil; Vaena, Daniel; Lowrance, William; Bratslavsky, Gennady; DeBenedette, Mark; Gamble, Alicia; Plachco, Ana; Norris, Marcus S; Horvatinovich, Joe; Tcherepanova, Irina Y; Nicolette, Charles A; Wood, Christopher G.
Afiliação
  • Figlin RA; Cedars-Sinai Medical Center Los Angeles, California.
  • Tannir NM; University of Texas, MD Anderson Cancer Center Houston, Texas.
  • Uzzo RG; Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.
  • Tykodi SS; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Chen DYT; Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.
  • Master V; Emory University Department of Urology, Emory University Hospital, Atlanta, Georgia.
  • Kapoor A; Urologic Cancer Centre for Research and Innovation, Hamilton, Ontario, Canada.
  • Vaena D; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.
  • Lowrance W; Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah.
  • Bratslavsky G; SUNY Upstate Medical University, Syracuse, New York.
  • DeBenedette M; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina. mdebenedette@coimmune.com.
  • Gamble A; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina.
  • Plachco A; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina.
  • Norris MS; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina.
  • Horvatinovich J; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina.
  • Tcherepanova IY; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina.
  • Nicolette CA; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina.
Clin Cancer Res ; 26(10): 2327-2336, 2020 05 15.
Article em En | MEDLINE | ID: mdl-32034074
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Carcinoma de Células Renais / Sunitinibe / Imunoterapia / Neoplasias Renais / Antígenos de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Carcinoma de Células Renais / Sunitinibe / Imunoterapia / Neoplasias Renais / Antígenos de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article